Novartis' everolimus gets EU nod for benign brain tumours
Pharma Times
The European Medicines Agency cleared everolimus yesterday for patients aged 3 years and older with subependymal giant cell astrocytoma (SEGA), a benign tumour type associated with the genetic disease tuberous sclerosis complex,which can cause ...
Novartis everolimus tablets wins EC approvalPharmaceutical Business Review

all 3 news articles »


More...